Development, validation and application of a sensitive LC–MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium-Reference-Cited by-同舟云学术

Development, validation and application of a sensitive LC–MS/MS method for the quantification of thalidomide in human serum, cells and cell culture medium

Published:2012-08 Issue: Volume:902 Page:16-26
ISSN:1570-0232
Container-title:Journal of Chromatography B
language:en
Short-container-title:Journal of Chromatography B

Author:

Roche Sandra,Sewell Louise,Meiller Justine,Pedersen Kasper,Rajpal Rajesh,O’Gorman Peter,Clynes Martin,O’Connor Robert

Publisher

Elsevier BV

Subject

Cell Biology,Clinical Biochemistry,Biochemistry,General Medicine,Analytical Chemistry

Reference46 articles.

1. The evolution of thalidomide and its IMiD derivatives as anticancer agents

2. THALIDOMIDE AND CONGENITAL ABNORMALITIES

3. THALIDOMIDE AND CONGENITAL ABNORMALITIES

4. Thalidomide in the treatment of lepra reactions

5. Antitumor Activity of Thalidomide in Refractory Multiple Myeloma

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanotechnology-based Drug Delivery Systems for the Treatment of Cervical Cancer: A Comprehensive Review;Current Nanoscience;2024-03

2. Thalidomide measurement in plasma and dried plasma spot by SPE combined with UHPLC-MS/MS for therapeutic drug monitoring;Bioanalysis;2022-08

3. Quantification of the organophosphate flame retardant triphenylphosphate and its main metabolite in whole blood by liquid–liquid micro-extraction and liquid chromatography-tandem mass spectrometry;Microchemical Journal;2021-09

4. Establishment of an in vitro method of rabbit embryo toxicity with toxicokinetics study;Journal of Applied Toxicology;2021-07-28

5. Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients;Clinical Pharmacology & Therapeutics;2020-05-09